MariMed appoints Edward Gildea as Chairman and Jon R. Levine as CEO

MARIMED INC.

Edward Gildea appointed Chairman of the Board, effective February 28, 2023.
Jon R. Levine appointed Chief Executive Officer, effective February 28, 2023.
Board amended Bylaws to revise powers and duties of Chairman, CEO, and President.
Amendment to Bylaws filed as Exhibit 3.2(A) with this 8-K.

item 5.03 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

MARIMED INC.: Amended Bylaws to revise powers and duties of Chairman, CEO, and President (effective 2023-02-28).

Change: bylaw amendment
Effective: 2023-02-28

Exact text from the filing

On February 28, 2023, the Board of Directors of MariMed Inc. (the “ Corporation ”), in conjunction with the appointment of Edward Gildea as Chairman of the Board and Jon R. Levine as Chief Executive Officer of the Corporation, authorized, approved and adopted an amendment the Corporation’s Bylaws (the “ Bylaws ”), to revise the powers and duties of the Corporation’s Chairman of the Board, Chief Executive Officer and President as set forth in Sections 4 and 5 of Article IV of the Bylaws, as amended.

View on SEC.gov

Browse all governance changes →

MARIMED INC. filing history →

Source: SEC EDGAR

accession 0001522767-23-000023

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.